Last reviewed · How we verify
Matching placebo of AYP-101 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Matching placebo of AYP-101 (Matching placebo of AYP-101) — AMIpharm Co., Ltd.. This is a matching placebo control and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching placebo of AYP-101 TARGET | Matching placebo of AYP-101 | AMIpharm Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching placebo of AYP-101 CI watch — RSS
- Matching placebo of AYP-101 CI watch — Atom
- Matching placebo of AYP-101 CI watch — JSON
- Matching placebo of AYP-101 alone — RSS
Cite this brief
Drug Landscape (2026). Matching placebo of AYP-101 — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-of-ayp-101. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab